almitrine has been researched along with Dyspnea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tellier, P | 1 |
| Ansquer, JC; Bertrand, A; Blaive, B; Charpin, J; Chrétien, J; Decroix, G; Kalb, JC; Lissac, J; Michel, FB; Morère, P | 1 |
| Ham, H; Michel, O; Sergysels, R | 1 |
| Bachand, RT; Bell, RC; Johanson, WG; Mullins, RC; West, LG | 1 |
| von Wichert, P; Wuttke, R | 1 |
| Bourgouin-Karaouni, D; Préfaut, C | 1 |
3 trial(s) available for almitrine and Dyspnea
| Article | Year |
|---|---|
[Dyspnea in chronic bronchitis patients. A method for diagnosis and monitoring therapeutic efficacy].
Topics: Almitrine; Bronchitis; Central Nervous System Stimulants; Chronic Disease; Dyspnea; Humans; Piperazines; Time Factors | 1984 |
The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
Topics: Adult; Aged; Almitrine; Clinical Trials as Topic; Double-Blind Method; Dyspnea; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Respiratory Function Tests | 1986 |
[Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
Topics: Administration, Oral; Adult; Almitrine; Bronchitis; Carbon Dioxide; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Humans; Hypoxia; Male; Middle Aged; Oxygen; Partial Pressure; Peak Expiratory Flow Rate; Piperazines; Random Allocation; Respiratory Function Tests; Vital Capacity | 1985 |
3 other study(ies) available for almitrine and Dyspnea
| Article | Year |
|---|---|
[Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
Topics: Almitrine; Bronchitis; Central Nervous System Stimulants; Chronic Disease; Drug Tolerance; Dyspnea; Female; Follow-Up Studies; Humans; Male; Piperazines; Pulmonary Gas Exchange; Respiratory Function Tests | 1985 |
Platypnea induced by worsening of VA/Q inhomogeneity in the sitting position in chronic obstructive lung disease.
Topics: Aged; Almitrine; Central Nervous System Stimulants; Dyspnea; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Piperazines; Posture; Ventilation-Perfusion Ratio | 1988 |
[Almitrine in daily practice].
Topics: Almitrine; Bronchitis; Carbon Dioxide; Dyspnea; Hemodynamics; Humans; Lung Diseases, Obstructive; Oxygen; Piperazines; Pneumonia; Respiratory Insufficiency | 1985 |